Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
ACS Nano ; 12(8): 7482-7496, 2018 08 28.
Artigo em Inglês | MEDLINE | ID: mdl-30071163

RESUMO

Chemotherapy protocols for childhood cancers are still problematic due to the high toxicity associated with chemotherapeutic agents and incorrect dosing regimens extrapolated from adults. Nanotechnology has demonstrated significant ability to reduce toxicity of anticancer compounds. Improvement in the therapeutic index of cytostatic drugs makes this strategy an alternative to common chemotherapy in adults. However, the lack of nanomedicines specifically for pediatric cancer care raises a medical conundrum. This review highlights the current state and progress of nanomedicine in pediatric cancer and discusses the real clinical challenges and opportunities.


Assuntos
Antineoplásicos/uso terapêutico , Nanomedicina/métodos , Neoplasias/tratamento farmacológico , Antineoplásicos/química , Criança , Humanos
2.
Cancer Lett ; 430: 193-200, 2018 08 28.
Artigo em Inglês | MEDLINE | ID: mdl-29802930

RESUMO

Osteosarcoma (OS) is the most frequent paediatric bone cancer, responsible for 9% of all cancer-related deaths in children. In this paper, a new strategy based on delivering edelfosine (ET) in lipid nanoparticles (LN) was explored in order to target the primary tumour and eliminate metastases. The in vitro and in vivo efficacy of the free drug, drug loaded into lipid nanoparticles (ET-LN) and doxorubicin (DOX) against osteosarcoma (OS) cells was analysed. ET and ET-LN decreased the growth of OS cells in vitro in a time- and dose-dependent manner. Interestingly, the uptake of ET and ET-LN was lower when OS cells were pre-treated with DOX. In vivo studies revealed that ET and ET-LN slowed down the primary tumour growth in two OS models. However, the combination of both drugs showed no additional anti-tumour effect. Importantly, ET-LN successfully prevented the metastatic spread of OS cells from the primary tumour to the lungs. On the whole, ET-LN are a promising candidate for OS chemotherapy.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Pulmonares/prevenção & controle , Osteossarcoma/tratamento farmacológico , Éteres Fosfolipídicos/administração & dosagem , Administração Oral , Animais , Neoplasias Ósseas/patologia , Linhagem Celular Tumoral , Doxorrubicina/administração & dosagem , Portadores de Fármacos/química , Composição de Medicamentos , Feminino , Humanos , Lipídeos/química , Neoplasias Pulmonares/secundário , Camundongos , Camundongos Nus , Nanopartículas/química , Osteossarcoma/patologia , Resultado do Tratamento , Ensaios Antitumorais Modelo de Xenoenxerto
3.
Cancer Lett ; 388: 262-268, 2017 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-27998763

RESUMO

Despite the great advances that have been made in osteosarcoma therapy during recent decades, recurrence and metastases are still the most common outcome of the primary disease. Current treatments include drugs such as doxorubicin (DOX) that produce an effective response during the initial exposure of tumor cells but sometimes induce drug resistance within a few cycles of chemotherapy. New therapeutic strategies are therefore needed to overcome this resistance. To this end, DOX was loaded into lipid nanoparticles (LN) and its efficacy was evaluated in commercial and patient-derived metastatic osteosarcoma cell lines. DOX efficacy was heavily influenced by passage number in metastatic cells, in which an overexpression of P-gp was observed. Notably, DOX-LN overcame the resistance associated with cell passage and improved DOX efficacy fivefold. Moreover, when DOX was co-administered with either free or encapsulated edelfosine (ET), a synergistic effect was observed. This higher efficacy of the combined treatment was found to be at least partially due to an increase in caspase-dependent cell death. The combination of DOX and ET is thus likely to be effective against osteosarcoma.


Assuntos
Doxorrubicina/uso terapêutico , Osteossarcoma/tratamento farmacológico , Éteres Fosfolipídicos/uso terapêutico , Doxorrubicina/farmacologia , Sinergismo Farmacológico , Humanos , Nanopartículas , Osteossarcoma/patologia , Éteres Fosfolipídicos/farmacologia
4.
Curr Pharm Des ; 21(42): 6104-24, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26503148

RESUMO

Osteosarcoma is the most frequent primary bone tumor in the pediatric age group. Its aggressive local growth pattern and its high propensity to metastasize, mainly to the lungs, give the disease an unfavorable prognosis that has situated this disease as one of the leading causes of pediatric cancer death. Current protocols for osteosarcoma treatment are based on neo-adjuvant (pre-operatory) chemotherapy followed by surgical resection of the tumor and a new phase of adjuvant chemotherapy. Despite the progress that these protocols have made in improving the outcome of the disease, the limited access of drugs to bone tumor and metastases, their indiscriminate distribution in the organism, the high required doses that cause intolerable toxicity and the development of multidrug resistance, still represent a major challenge. Nanotechnology has emerged as a new strategy to successfully address these problems by the development of nanoscaled drug carriers that present the ability to target the drug to the tumor cells, achieving high drug concentrations in the tumor area, while decreasing its presence in healthy tissues and therefore its potential systemic toxicity. This review summarizes the different lipid nanocarriers developed to deliver first and second-line anti-osteosarcoma drugs as well as emerging agents in the treatment of this disease. Moreover, it also discusses the potential of these nanocarriers for the treatment of osteosarcoma.


Assuntos
Neoplasias Ósseas/tratamento farmacológico , Nanopartículas , Osteossarcoma/tratamento farmacológico , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/uso terapêutico , Neoplasias Ósseas/cirurgia , Criança , Terapia Combinada , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos , Humanos , Lipídeos/química , Osteossarcoma/cirurgia
5.
BMC Public Health ; 15: 2, 2015 Feb 13.
Artigo em Inglês | MEDLINE | ID: mdl-25971903

RESUMO

BACKGROUND: Common interventions for smoking cessation are based on medical advice and pharmacological aid. Information and communication technologies may be helpful as interventions by themselves or as complementary tools to quit smoking. The objective of the study was to determine the use of information and communication technologies (ICTs) in the smoking population attended in primary care, and describe the major factors associated with its use. METHODS: Descriptive observational study in 84 health centres in Cataluña, Aragon and Salamanca. We included by simple random sampling 1725 primary healthcare smokers (any amount of tobacco) aged 18-85. Through personal interview professionals collected Socio-demographic data and variables related with tobacco consumption and ICTs use were collected through face to face interviews Factors associated with the use of ICTs were analyzed by logistic regression. RESULTS: Users of at least one ICT were predominantly male, young (18-45 years), from most favoured social classes and of higher education. Compared with non-ICTs users, users declared lower consumption of tobacco, younger onset age, and lower nicotine dependence. The percentages of use of email, text messages and web pages were 65.3%, 74.0% and 71.5%, respectively. Factors associated with the use of ICTs were age, social class, educational level and nicotine dependence level. The factor most closely associated with the use of all three ICTs was age; mainly individuals aged 18-24. CONCLUSIONS: The use of ICTs to quit smoking is promising, with the technology of mobile phones having a broader potential. Younger and more educated subjects are good targets for ICTs interventions on smoking cessation.


Assuntos
Comunicação em Saúde/métodos , Promoção da Saúde/métodos , Atenção Primária à Saúde/métodos , Abandono do Hábito de Fumar/métodos , Prevenção do Hábito de Fumar , Tabagismo/prevenção & controle , Adulto , Idoso , Aconselhamento/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fumar/epidemiologia , Mídias Sociais/estatística & dados numéricos , Espanha/epidemiologia , Tabagismo/epidemiologia , Adulto Jovem
6.
Soft Matter ; 10(11): 1767-77, 2014 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-24652455

RESUMO

A new method to form a nanoparticle-structured hydrogel is reported; it is based on the drug being loaded into the nanoparticles to form a solid structure. A lipophilic form of gemcitabine (modified lauroyl), an anti-cancer drug, was encapsulated in lipid nanocapsules (LNCs), using a phase-inversion temperature process. A gel was formed spontaneously, depending on the LNC concentration. The drug loading, measured with total entrapment efficiency, and the rheological properties of the gel were assessed. Physical studies (surface tension measurements) showed that modified gemcitabine was localised at the oil-water interface of the LNC, and that the gemcitabine moieties of the prodrug were exposed to the water phase. This particular assembly promoted inter-LNC interactions via hydrogen bonds between gemcitabine moieties that led to an LNC gel structure in water, without a matrix, like a tridimensional pearl necklace. Dilution of the gel produced a gemcitabine-loaded LNC suspension in water, and these nanoparticles presented cytotoxic activity to various cancer cell lines to a greater degree than the native drug. Finally, the syringeability of the formulation was successfully tested and perspectives of its use as a nanomedicine (intratumoural or subcutaneous injection) can be foreseen.


Assuntos
Desoxicitidina/análogos & derivados , Portadores de Fármacos/administração & dosagem , Nanocápsulas/administração & dosagem , Nanomedicina , Linhagem Celular Tumoral , Desoxicitidina/administração & dosagem , Desoxicitidina/química , Portadores de Fármacos/química , Humanos , Hidrogel de Polietilenoglicol-Dimetacrilato/administração & dosagem , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Lipídeos/química , Nanocápsulas/química , Nanopartículas/administração & dosagem , Nanopartículas/química , Gencitabina
7.
Metas enferm ; 8(7): 71-76, sept. 2005. ilus
Artigo em Es | IBECS | ID: ibc-041797

RESUMO

Del profesional enfermero del futuro se espera que dé respuesta a lasnecesidades de la comunidad en la que desempeña su labor, asegurandola prestación de cuidados preventivos y curativos tanto en situaciónde salud como de enfermedad. Dicha asistencia sólo tiene cabidadentro de un sistema educativo cuyos contenidos respondan a las demandasque, de manera implícita o explícita, son formuladas en el senode la sociedad. La educación sexual se ha ido incorporando desdehace tiempo en los programas formativos de los estudiantes de pregradode Enfermería en nuestro país. En este contexto y partiendo denuestro firme compromiso por propiciar un aprendizaje significativoen los discentes, se ha puesto en marcha, desde hace dos años, el seminariode métodos anticonceptivos que a continuación presentamosy que ha ido dirigido a alumnos de Tercer curso de Enfermería. Su elaboraciónobedece a una convicción que compartimos ya muchos docentes:la necesidad de incorporar a la enseñanza en Ciencias de laSalud elementos básicos del ámbito de la metodología educativa, loscuales resultan imprescindibles para la elaboración de proyectos quepersigan un objetivo tan ambicioso como el propuesto. Desde la necesidaddel saber conocer, saber hacer, saber estar con los otros y saberser, la teoría se entremezcla con la práctica y el desarrollo de actitudesimprescindibles para el enfermero del siglo XXI


The future nursing professional is expected to give answers to the needsof the community in which he or she is carrying out the profession,ensuring the provision of preventive and curative care, both insickness and in health. Such care can only be envisioned within aneducation system the contents of which respond to the demandsthat, either implicit or explicitly, are required from the core of society.For quite some time now sexual education has gradually come toform part of the education curriculum of pregraduate nursing studentsin our country. Within this context and taking as our startingpoint our commitment to promote a significant learning two yearsago a seminar on contraceptive methods was started (which we willdescribe below) that was aimed at third year nursing students. Its elaborationobeys to a conviction shared by many of us, teachers, whichis the need to incorporate basic elements in the setting of educationalmethodology to the teaching of health sciences, which are essentialto elaborate projects that pursue an objective as ambitious as the oneproposed. From the need of learning, of knowing how to do things,how to be with others, and the need for the learning of the knowhow, theory is combined with practice aiding in the development ofessential attitudes that the nurse of the XXI century will need to have


Assuntos
Educação em Enfermagem/tendências , Pesquisa em Avaliação de Enfermagem/educação , Dispositivos Anticoncepcionais , Anticoncepcionais , Educação Sexual/métodos , Educação de Pós-Graduação em Enfermagem/tendências , Enfermagem Materno-Infantil/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...